全文获取类型
收费全文 | 23092篇 |
免费 | 2153篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 204篇 |
儿科学 | 903篇 |
妇产科学 | 504篇 |
基础医学 | 2957篇 |
口腔科学 | 479篇 |
临床医学 | 2560篇 |
内科学 | 4789篇 |
皮肤病学 | 187篇 |
神经病学 | 2141篇 |
特种医学 | 1000篇 |
外科学 | 3166篇 |
综合类 | 446篇 |
一般理论 | 12篇 |
预防医学 | 2491篇 |
眼科学 | 478篇 |
药学 | 1549篇 |
中国医学 | 35篇 |
肿瘤学 | 1396篇 |
出版年
2022年 | 142篇 |
2021年 | 345篇 |
2020年 | 208篇 |
2019年 | 404篇 |
2018年 | 402篇 |
2017年 | 270篇 |
2016年 | 325篇 |
2015年 | 359篇 |
2014年 | 615篇 |
2013年 | 931篇 |
2012年 | 1234篇 |
2011年 | 1251篇 |
2010年 | 713篇 |
2009年 | 661篇 |
2008年 | 1156篇 |
2007年 | 1266篇 |
2006年 | 1167篇 |
2005年 | 1140篇 |
2004年 | 1108篇 |
2003年 | 1081篇 |
2002年 | 1077篇 |
2001年 | 498篇 |
2000年 | 520篇 |
1999年 | 463篇 |
1998年 | 340篇 |
1997年 | 273篇 |
1996年 | 295篇 |
1995年 | 272篇 |
1994年 | 269篇 |
1993年 | 258篇 |
1992年 | 377篇 |
1991年 | 308篇 |
1990年 | 344篇 |
1989年 | 377篇 |
1988年 | 301篇 |
1987年 | 310篇 |
1986年 | 326篇 |
1985年 | 288篇 |
1984年 | 268篇 |
1983年 | 253篇 |
1982年 | 199篇 |
1981年 | 217篇 |
1980年 | 166篇 |
1979年 | 224篇 |
1978年 | 194篇 |
1977年 | 142篇 |
1976年 | 154篇 |
1975年 | 151篇 |
1974年 | 148篇 |
1973年 | 148篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
Sutada Lotinun Glenda L Evans James T Bronk Mark E Bolander Thomas J Wronski Erik L Ritman Russell T Turner 《Journal of bone and mineral research》2004,19(7):1165-1171
We examined the time course effects of continuous PTH on cortical bone and mechanical properties. PTH increased cortical bone turnover and induced intracortical porosity with no deleterious effect on bone strength. Withdrawal of PTH increased maximum torque to failure and stiffness with no change in energy absorbed. INTRODUCTION: The skeletal response of cortical bone to parathyroid hormone (PTH) is complex and species dependent. Intermittent administration of PTH to rats increases periosteal and endocortical bone formation but has no known effects on intracortical bone turnover. The effects of continuous PTH on cortical bone are not clearly established. MATERIALS AND METHODS: Eighty-four 6-month-old female Sprague-Dawley rats were divided into three control, six PTH, and two PTH withdrawal (WD) groups. They were subcutaneously implanted with osmotic pumps loaded with vehicle or 40 microg/kg BW/day human PTH(1-34) for 1, 3, 5, 7, 14, and 28 days. After 7 days, PTH was withdrawn from two groups of animals for 7 (7d-PTH/7d-WD) and 21 days (7d-PTH/21d-WD). Histomorphometry was performed on periosteal and endocortical surfaces of the tibial diaphysis in all groups. microCT of tibias and mechanical testing by torsion of femora were performed on 28d-PTH and 7d-PTH/21d-WD animals. RESULTS AND CONCLUSIONS: Continuous PTH increased periosteal and endocortical bone formation, endocortical osteoclast perimeter, and cortical porosity in a time-dependent manner, but did not change the mechanical properties of the femur, possibly because of addition of new bone onto periosteal and endocortical surfaces. Additionally, withdrawal of PTH restored normal cortical porosity and increased maximum torque to failure and stiffness. We conclude that continuous administration of PTH increased cortical porosity in rats without having a detrimental effect on bone mechanical properties. 相似文献
22.
23.
24.
K. W. Stephen J. I. Russell S. L. Creanor C. K. Burchell 《Community dentistry and oral epidemiology》1987,15(2):90-94
Fibre optic transillumination (FOTI) has been employed during the course of a 3-yr clinical dentifrice trial which initially involved 3003 children. At the initial examination, a subgroup of 813 13-yr-olds, and at the following annual visit, 2247 14-yr-olds, were examined using a 150 W lamp and 0.5 mm diameter probe. Routine clinical and radiographic examinations were performed separately. Compared to the clinical scores for anterior teeth, FOTI detected an additional 64% of interproximal lesions at the first visit while, for the larger number of children at the second visit, the increase in lesion detection level using FOTI was 37%. For the posterior teeth the comparable figure at the second examination was 92%. When FOTI data were compared to radiographic data for more than 52,000 posterior interproximal surfaces, FOTI could only detect 17% of radiographic Grade 2 lesions and 48% Grade 3 lesions. Thus any assumption that FOTI diagnoses may be a substitute for bitewing radiography appears premature. 相似文献
25.
26.
27.
Michael Lefevre Author Vitae Penny M. Kris-EthertonAuthor Vitae Guixiang ZhaoAuthor Vitae Russell P. TracyAuthor Vitae 《Journal of the American Dietetic Association》2004,104(3):410-419
The cause of many myocardial infarctions is occlusive thrombosis, or a blood clot that stops blood flow in a coronary artery. Hemostasis involves a complex system of factors, which normally form and degrade blood clots, that work within a delicate balance. Emerging evidence suggests that some hemostatic factors, including factor VII, fibrinogen, and plasminogen activator inhibitor-1, are associated with increased risk for cardiovascular disease (CVD). Accumulating evidence suggests a relationship between dietary fatty acids and emerging hemostatic CVD risk factors, although much of this evidence is incomplete or conflicting. Dietary supplementation with marine n-3 fatty acids prolongs bleeding time and may decrease risk for thrombosis. Factor VII coagulant activity modestly decreases with reductions in saturated fatty acid (SFA) intake and thereby may contribute to the beneficial effects of low SFA diets. Large triglyceride-rich particles formed during postprandial lipemia can support the assembly and function of coagulation complexes and seem to play a role in the activation of factor VII, and thus may partially explain increased CVD risk associated with increased postprandial triglyceridemia. As our understanding of the role of dietary fatty acids and hemostasis evolves, it is likely that we will be able to make specific dietary recommendations to further decrease CVD risk. At this juncture, however, increasing marine n-3 fatty acids and decreasing certain SFAs are leading strategies to reduce hemostatic CVD risk factors. An array of dietary strategies that target multiple CVD risk factors could have a greater impact on CVD than a single risk factor intervention strategy. 相似文献
28.
29.
We have determined the frequency of heterozygosity of the short arm of chromosome 17 in 20 cervical tumours using the highly polymorphic probe pYNZ22. Only 25% of the tumours were heterozygous at this locus. This is significantly lower than the level of 86% heterozygosity for this locus in the general population indicating that loss of one allele occurs in cervical cancer. Heterozygosity for a locus on the long arm of the same chromosome showed no significant difference between the tumours and the general population indicating that genetic loss was confined to the short arm of the chromosome. The analysis of premalignant lesions showed 70% of patients were heterozygous suggesting that loss of material from the short arm of chromosome 17 took place at a late stage in tumour development. This report confirms predictions made from previous karyotypic analysis and is the first indication of allele loss on the short arm of chromosome 17 in cervical cancer. 相似文献
30.
F M Muggia E LePoidevin S Jeffers C Russell W Boswell C P Morrow J Curtin J Schlaerth 《Annals of oncology》1992,3(2):149-154
Nineteen patients with ovarian cancer and minimal residual or persistent disease who were treated with cisplatin or carboplatin-based intraperitoneal (IP) regimens had distribution studies of IP contrast and computerized tomography prior to and during treatment. The distribution pattern was assessed retrospectively and scored for the presence of contrast in each of eight regions: the under surface of right and left diaphragms, the right and left paracolic gutters, the lesser omental sac, the intramesenteric region and the true and false pelvis. Assigning a point to each region with adequate distribution, we classified 10 patients to an excellent pattern (greater than or equal to 7 of 8 regions), 6 to a good pattern (5 to less than 7 regions), and 3 to an inadequate distribution pattern (less than 5 regions). Serial studies were performed in 8 patients after more than 4 cycles of IP therapy. In these patients, all of whom were tolerating treatment without progression, the distribution remained virtually unchanged for those with excellent distribution. One of three with good distribution manifested inadequate distribution on repeat study, and one of two with inadequate distribution improved to show a good pattern. In this small study there was no correlation of distribution patterns with plasma CA-125 at onset of IP treatment and prior surgical procedures or placement of the catheter tip. However, three patients with unsatisfactory patterns had procedures consisting of catheter placement only rather than formal reassessment laparotomies for ovarian cancer. Since satisfactory IP distribution may be required for obtaining a therapeutic advantage from IP therapy, methods for its assessment must be developed.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献